SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 13, 2026

BBIO

BridgeBio Pharma, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $11.6M total
Actionable Insight • Neutral

The insider sales are routine post-exercise diversification by non-executive directors and are immaterial relative to market cap. No C-suite selling or cross-filing red flags exist. Monitor for any C-suite open-market sales or a material increase in selling volume above 0.1% of market cap, which would warrant a more bearish read.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$84.09
T+0 close · Jul 13, 2026 · via day close
Latest settled
−20.92%
T+60 · $66.50
Vs SPY
−24.30%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 14 $84.09entry
  2. T+1 · 4mo ago −1.70%α −2.10% · $82.66
  3. T+5 · 4mo ago −1.95%α −1.48% · $82.45
  4. T+20 · 3mo ago −0.46%α −2.96% · $83.70
  5. T+60 · 6w ago −20.92%α −24.30% · $66.50
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two BridgeBio directors executed open-market sales totaling $11.56M on July 9, 2026, following derivative exercises. Director Cook sold $10.12M at $90/share and Director Ellis sold $1.44M at $84/share. The sales represent ~0.07% of the $16.3B market cap, falling below the 0.1% materiality threshold, and are consistent with routine post-exercise diversification. No C-suite executives participated, and the cluster is not amplified by any cross-filing context that would suggest informed selling.

Key Financial Metrics

Direction
selling
Total Value
$11.6M
Insiders
2

Key Facts

  • Two directors (Cook and Ellis) sold a combined $11.56M in open-market transactions on July 9, 2026
  • Director Cook sold 112,422 shares at $90/share ($10.12M) and 36,167 shares at $84/share ($3.04M)
  • Director Ellis sold 17,167 shares at $84/share ($1.44M)
  • All sales followed derivative exercises at prices between $0 and $29/share, generating non-cash gains
  • Total open-market sales represent ~0.07% of BridgeBio's $16.3B market cap
  • No C-suite executives (CEO, CFO, COO) participated in the cluster
  • No 10b5-1 plan designation was noted in the filings
  • The cluster is not accompanied by any earnings, restructuring, or late-filing context that would amplify its significance

Financial Impact

Total open-market sales of $11.56M, representing ~0.07% of market cap, below the 0.1% materiality threshold for insider clusters

insider ownershipdilution

Risk Factors

  • Insider selling could accelerate if the stock continues to appreciate, but current levels are not alarming
  • Derivative exercises add to public float, though the ~149K shares exercised are negligible for a $16.3B company

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (30 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BBIO-1784009308941

Track record

38 reports on BBIO

Performance horizon

10 of 13 bullish or bearish reports moved the stock their way by T+20. Best: +26.76% at T+60 after the May 11, 2026 report. 14 of 15 went positive at some point.

Filters
  1. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $78.17 Now $78.30 +0.17% settles Dec 11
  2. Nov 9, 20267d ago Institutional Cluster Bullish 4/10 Entry $77.93 Now $78.30 +0.47% settles Dec 8
  3. Nov 6, 202610d ago Press Release Neutral 2/10 Entry $77.93 Now $78.30 +0.47% settles Dec 8
  4. Oct 29, 202618d ago 8-K Bullish 6/10 No price data
  5. Oct 29, 202618d ago Press Release Bullish 6/10 Entry $74.95 Now $78.30 +4.47% settles Nov 30
  6. Oct 27, 202620d ago SC 13G Neutral 3/10 Entry $70.82 Now $78.30 +10.56% settles Nov 25
  7. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $68.12 Now $78.30 +14.94% settles Nov 19
  8. Oct 13, 20264w ago 8-K Bullish 7/10 Entry $63.30 to $78.67 Now $78.30 +23.70% ▲ +24.28% +27.89% vs SPY
  9. Oct 6, 20265w ago Press Release Bullish 7/10 Entry $66.96 to $74.03 Now $78.30 +16.94% ▲ +10.56% +13.73% vs SPY
  10. Oct 5, 20266w ago Press Release Neutral 2/10 Entry $66.96 to $74.03 Now $78.30 +16.94% ▲ +10.56% +13.73% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens Wed (12h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 14, 2026